| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Reitan Colleen F is a Director at MYRIAD GENETICS INC with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 18 sells.
Estimated insider holdings value: $623K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 18,000 | $467.60 | $8,416,729.64 | -12.2% | -10.8% | - | |
| Apr 16, 2025 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sell | 36 | $232.86 | $8,382.96 | -100% | +35.0% | - | |
| Oct 17, 2024 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Buy | 36 | $287.85 | $10,362.68 | +112.5% | -15.4% | +62.3% | |
| Sep 3, 2024 | MYGN Myriad Genetics Inc | Director | Sell | 46,012 | $27.95 | $1,285,851.35 | -52.0% | -39.2% | -75.2% |